PROSTATE cancerANDROGEN deprivation therapyTHERAPEUTICSHORMONE therapyThe emergence of resistance to prostate cancer (PCa) treatment, particularly to androgen deprivation therapy (ADT), has posed a significant challenge in the field of PCa management. Among the therapeutic options ...
"The success of TULSA represents a revolution in whole-gland treatment forprostate cancer," said lead author Steven S. Raman, M.D., FASR, FSIR, professor of radiology, urology and surgery at the David Geffen School of Medicine at UCLA. "Prostate cancer is the most common form of cancer ...
Ad In this study, published in the journalFrontiers in Pharmacology, they propose a new treatment based on a combination of kinase inhibitors in patients who inevitably stop responding todocetaxel. The team found that resistance to this drug is associated with the hyperactivation of the cellular pat...
In addition to emerging treatment options, the speakers addressed the importance of individualized decision-making when treating patients with multiple myeloma. Image credit: freshidea | stock.adobe.com During a presentation at the National Comprehensive Cancer Network Annual 2024 Conference in Orlando, ...
Dr Sandy Srinivas highlights new data on treatment efficacy, negative trial outcomes, and notable quality-of-life improvements for patients.
Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer The increasing potency of therapies that target the androgen receptor (AR) signalling axis has correlated with a rise in the proportion of patients with prostate cancer harbouring an adaptive phenotype, termed treatment-indu...
Traditional Chinese medicine and pharmacy in the treatment of prostate cancer field is in the initial stage.It has great potential and prospects for development in improving the quality of life of patients,delaying tumor metastasis and progression.In this paper,traditional Chinese medicine treatment of...
EC is a common gastrointestinal malignancy, ranking the seventh and sixth in global cancer incidence and mortality, respectively [19]. ESCC is the dominant histological subtype of EC and has the highest incidence in China [20]. Despite the great progress in clinical treatment and targeted therapies...
About Barrigel™ Rectal SpacerBarrigel™ rectal spacer is the first and only hyaluronic acid rectal spacer that separates the prostate from the rectum to protect the rectum during radiation therapy treatment for prostate cancer.1 Barrigel is made from Non-Animal Stabilized Hyaluronic Aci...
Early diagnosis and treatment are essential to decrease cancer mortality; however, for many common types of cancer, including prostate, breast, thyroid, andcervical cancer, overtreatment is a growing concern. Overtreatment can occur when an individual undergoes medical therapies for cancer that will not...